Skip to content
Back to LCTX

Lineage Cell Therapeutics, Inc.

Open-market purchases and sales reported on SEC Forms 4 and 5, with each filing and its footnotes.

Since Nov 18, 2025
Transactions
4
Purchases
4
Sales
0
Purchase value
$98.57K
Sale value
$0.00

Values are shares multiplied by reported price when both were supplied, each trade counted once however many filers reported it.

Deborah J AndrewsDirector
4
Filed Nov 17, 2026Period of report Nov 16, 20260001193125-26-465809
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseNov 16, 2026
Common Shares25,000$0.80$20.00K40,578Direct
Open on SEC EDGAR
Brian M CulleyDirector · President and CEO
4
Filed Nov 17, 2026Period of report Nov 16, 20260001193125-26-464849
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseNov 16, 2026
Common SharesF140,500$0.916$37.10K296,016Direct
Filing footnotes · 1
  1. F11. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.85 to $1.00 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within theranges set forth in this footnote 1.
Open on SEC EDGAR
Jill Ann HoweChief Financial Officer
4
Filed Nov 16, 2026Period of report Nov 16, 20260001193125-26-463787
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseNov 16, 2026
Common SharesF120,000$0.855$17.10K45,500Direct
Filing footnotes · 1
  1. F11. The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $0.84 to $0.94 inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within theranges set forth in this footnote 1.
Open on SEC EDGAR
Brian M CulleyDirector · President and CEO
4
Filed Mar 12, 2026Period of report Mar 12, 20260001193125-26-104106
TransactionSecuritySharesPriceValueHeld afterOwnership
PurchaseMar 12, 2026
Common SharesF115,000$1.625$24.38K255,516Direct
Filing footnotes · 1
  1. F1The price reported is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.61 to $1.63, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote 1.
Open on SEC EDGAR

P and S transaction codes only. Grants, gifts, option exercises, tax withholding, and Form 144 notices are not counted as purchases or sales. A row whose filed price fails a plausibility check, or that is not common stock, is listed but left out of the values; a trade reported by several filers is counted once.